AmeriCann, Inc. (ACAN) ist ein börsennotiertes Unternehmen im Immobilien Sektor, tätig in der Real Estate - Services Branche. Der Hauptsitz des Unternehmens ist in Denver, CO, United States. Der aktuelle CEO ist Timothy Ryan Keogh.
ACAN hat IPO-Datum 2014-07-10, 3 Vollzeitbeschäftigte, gelistet an der Other OTC, eine Marktkapitalisierung von $2.44K.
AmeriCann, Inc. operates as a specialized cannabis company in the United States. It designs, develops, leases, and operates cultivation, processing, and manufacturing facilities for licensed cannabis businesses. The company's flagship project is the Massachusetts Cannabis Center that is developed on a 52-acre parcel of land located in Freetown, southeastern Massachusetts. It also provides medical cannabis and adult-use cannabis. The company was formerly known as Nevada Health Scan, Inc. and changed its name to AmeriCann, Inc. in 2014. The company was incorporated in 2010 and is based in Denver, Colorado.
